[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f43zCfYXknoi4qmh_jqT9OivLJxDTg1xFKK_17LmQch0":3},{"locale":4,"topic":5,"relatedTrends":385},"en",{"topic":6,"slug":7,"canonicalSlug":7,"topicAliases":8,"nicheKey":22,"nicheName":23,"nicheNameEn":24,"nicheIcon":25,"country":26,"countries":27,"agentKey":28,"score":29,"type":30,"isFresh":31,"isPublic":31,"detectedAt":32,"sources":33,"evidence":381},"Daraxonrasib significantly extends survival in pancreatic cancer","daraxonrasib-significantly-extends-survival-in-pancreatic-cancer",[9,10,11,12,13,14,15,16,17,18,19,20,21],"Daraxonrasib targeted therapy extending pancreatic cancer survival","Daraxonrasib KRAS-targeting oral therapy for pancreatic cancer","Daraxonrasib extends survival in previously treated metastatic pancreatic cancer","Revolution Medicines' daraxonrasib extending metastatic pancreatic cancer survival","daraxonrasib as treatment for pancreatic cancer","Daraxonrasib new targeted drug for pancreatic cancer patients","experimental oral pancreatic cancer drug daraxonrasib improving survival","daraxonrasib extending lives in previously treated metastatic pancreatic cancer","Revolutionary drug for previously treated metastatic pancreatic cancer","Daraxonrasib hailed as revolutionary treatment for metastatic pancreatic cancer","Revolution Medicines' daraxonrasib hailed as revolutionary pancreatic cancer treatment","Daraxonrasib hailed as revolutionary new treatment for pancreatic cancer","Academic research contributions to daraxonrasib pancreatic cancer treatment","sante","Santé & Médecine","Health & Medicine","🏥","CN",[26],"sante-CN",100,"spiking",false,"2026-06-01T02:13:28.737Z",[34,40,46,51,56,61,66,71,76,81,86,91,96,101,106,111,116,121,126,131,136,141,146,150,155,160,165,169,174,178,183,188,193,197,202,207,212,217,222,227,232,236,241,246,251,253,258,262,267,272,277,282,287,292,297,302,307,312,317,322,327,332,337,342,347,352,358,362,367,372,376],{"title":35,"url":36,"domain":37,"snippet":38,"content":39},"Patients, doctors hail ‘revolutionary’ new drug for pancreatic cancer","https:\u002F\u002Fwww.wbez.org\u002Fhealth-medicine\u002F2026\u002F05\u002F31\u002Fpancreatic-cancer-daraxonrasib-early-access-treatment","wbez.org","The FDA granted some patients early access to daraxonrasib after studies showed the drug from Revolution Medicines can considerably extend survival for people with pancreatic cancer.","](https:\u002F\u002Fwww.chicagopublicmedia.org\u002F)\n\n](https:\u002F\u002Fchicago.suntimes.com\u002F)\n\n](https:\u002F\u002Fwww.wbez.org\u002F)\n\nMenu\n\n](https:\u002F\u002Fwww.wbez.org\u002F)\n\n!\n\n!\n\nResearchers at Silicon Valley-based company Revolution Medicines developed the promising new drug daraxonrasib. It’s the first treatment to considerably extend the lives of patients with pancreatic cancer.\n\nRevolution Medicines\n\n](https:\u002F\u002Fwww.wbez.org\u002F)\n\n[Content truncated...]",{"title":41,"url":42,"domain":43,"snippet":44,"content":45},"Daraxonrasib significantly extends survival in metastatic pancreatic cancer","https:\u002F\u002Fwww.news-medical.net\u002Fnews\u002F20260531\u002FDaraxonrasib-significantly-extends-survival-in-metastatic-pancreatic-cancer.aspx","news-medical.net","At the ASCO annual meeting, Dana-Farber's Brian Wolpin, MD, MPH, will present positive results from the RASolute 302 trial showing a substantial...",null,{"title":47,"url":48,"domain":49,"snippet":50,"content":45},"Investigational targeted therapy doubles survival in metastatic pancreatic cancer","https:\u002F\u002Fwww.uclahealth.org\u002Fnews\u002Frelease\u002Finvestigational-targeted-therapy-doubles-survival-metastatic","uclahealth.org","In an international study co-led by UCLA, investigators found an investigational targeted therapy significantly extended overall survival for patients with...",{"title":52,"url":53,"domain":54,"snippet":55,"content":45},"Experimental pill offers breakthrough hope in pancreatic cancer fight | Daily Sabah","https:\u002F\u002Fwww.dailysabah.com\u002Flife\u002Fhealth\u002Fexperimental-pill-offers-breakthrough-hope-in-pancreatic-cancer-fight\u002Famp","dailysabah.com","An experimental drug for advanced pancreatic cancer significantly extended survival in a major clinical trial, offering fresh hope for improved treatment...",{"title":57,"url":58,"domain":59,"snippet":60,"content":45},"Revolution Medicines Reports Breakthrough Phase 3 Results for Daraxonrasib in Metastatic Pancreatic Cancer","https:\u002F\u002Fwww.quiverquant.com\u002Fnews\u002FRevolution+Medicines+Reports+Breakthrough+Phase+3+Results+for+Daraxonrasib+in+Metastatic+Pancreatic+Cancer","quiverquant.com","Revolution Medicines reports significant survival benefits for daraxonrasib in Phase 3 trial for met.",{"title":62,"url":63,"domain":64,"snippet":65,"content":45},"Revolution Medicines reports Phase 3 win in pancreatic cancer (RVMD:NASDAQ)","https:\u002F\u002Fseekingalpha.com\u002Fnews\u002F4598698-revolution-medicines-reports-phase-3-win-in-pancreatic-cancer","seekingalpha.com","Revolution Medicines (RVMD) reported Phase 3 clinical trial results showing its experimental cancer drug daraxonrasib significantly extended survival for...",{"title":67,"url":68,"domain":69,"snippet":70,"content":45},"Experimental pill helps people with advanced pancreatic cancer live longer, researchers say","https:\u002F\u002Fwww.fox13news.com\u002Fnews\u002Fexperimental-pill-helps-people-advanced-pancreatic-cancer-live-longer-researchers-say.amp","fox13news.com","An experimental pill helped people with one of the most deadly cancers in the world live longer, researchers reported this weekend.",{"title":72,"url":73,"domain":74,"snippet":75,"content":45},"New drug offers hope for advanced pancreatic cancer treatment","https:\u002F\u002Funb.com.bd\u002Fcategory\u002FWorld\u002Fnew-drug-offers-hope-for-advanced-pancreatic-cancer-treatment\u002F187081","unb.com.bd","An experimental drug has shown encouraging results in treating advanced pancreatic cancer, offering fresh hope for patients battling one of the deadliest...",{"title":77,"url":78,"domain":79,"snippet":80,"content":45},"Experimental pancreatic cancer pill doubles survival chances, boosts quality of life","https:\u002F\u002Fwww.straitstimes.com\u002Fworld\u002Fexperimental-pancreatic-cancer-pill-doubles-survival-boosts-quality-of-life","straitstimes.com","Revolution Medicine's daraxonrasib pill significantly doubled survival for advanced pancreatic cancer patients, reducing death risk by 60 per cent.",{"title":82,"url":83,"domain":84,"snippet":85,"content":45},"New Drug Offers Extended Life for Advanced Pancreatic Cancer Patients","https:\u002F\u002Fwww.devdiscourse.com\u002Farticle\u002Fhealth\u002F3927770-new-drug-offers-extended-life-for-advanced-pancreatic-cancer-patients","devdiscourse.com","An innovative pill, daraxonrasib, has been shown to extend the lives of people with advanced pancreatic cancer, increasing survival times significantly over...",{"title":87,"url":88,"domain":89,"snippet":90,"content":45},"ASCO26: RevMed’s daraxonrasib presents a turning point for pancreatic cancer","https:\u002F\u002Fwww.pharmaceutical-technology.com\u002Fanalyst-comment\u002Fasco26-revmeds-daraxonrasib-presents-a-turning-point-for-pancreatic-cancer\u002F","pharmaceutical-technology.com","The field is ecstatic about the prospect of a targeted therapy meaningfully extending overall survival in pancreatic cancer.",{"title":92,"url":93,"domain":94,"snippet":95,"content":45},"Daily pill can double survival time for world’s deadliest cancer, trial shows","https:\u002F\u002Fwww.theguardian.com\u002Fsociety\u002F2026\u002Fmay\u002F31\u002Fdaily-pill-daraxonrasib-double-survival-time-pancreatic-pancreas-cancer-clinical-trial","theguardian.com","Experts hail daraxonrasib as 'gamechanger' for patients with advanced pancreatic cancer.",{"title":97,"url":98,"domain":99,"snippet":100,"content":45},"How Daraxonrasib Could Improve Pancreatic Cancer Treatment, Offering New Hope","https:\u002F\u002Fwww.mskcc.org\u002Fnews\u002Fhow-daraxonrasib-could-improve-pancreatic-cancer-treatment-offering-new-hope","mskcc.org","A highly anticipated clinical trial of the targeted drug daraxonrasib suggests it may open a whole new era in treating pancreatic cancer, after the drug...",{"title":102,"url":103,"domain":104,"snippet":105,"content":45},"This new drug could change how we treat one of the deadliest cancers","https:\u002F\u002Fwww.pbs.org\u002Fnewshour\u002Fhealth\u002Fpancreatic-cancer-is-deadly-and-difficult-to-treat-a-new-pill-could-change-that","pbs.org","The overall survival rate for people who got daraxonrasib was 13.2 months, nearly double the 6.7 months people survived on standard chemotherapy alone.",{"title":107,"url":108,"domain":109,"snippet":110,"content":45},"Research Spotlight: A New Era of Progress Against Pancreatic Cancer","https:\u002F\u002Fpancan.org\u002Fnews\u002Fresearch-spotlight\u002Fresearch-spotlight-a-new-era-of-progress-against-pancreatic-cancer\u002F","pancan.org","PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit explains why we are in a new era of progress against pancreatic cancer.",{"title":112,"url":113,"domain":114,"snippet":115,"content":45},"A new pancreatic cancer pill may be a game changer for patients","https:\u002F\u002Fwww.sciencenews.org\u002Farticle\u002Fpancreatic-cancer-pill-daraxonrasib","sciencenews.org","Daraxonrasib, which nearly doubled patients' survival time, fights the disease in a new way. It bear-hugs a cancer protein that drives cell growth.",{"title":117,"url":118,"domain":119,"snippet":120,"content":45},"‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long","https:\u002F\u002Fwww.washingtonpost.com\u002Fhealth\u002F2026\u002F05\u002F31\u002Fhotly-anticipated-pancreatic-cancer-drug-results-open-new-era-lethal-cancer\u002F","washingtonpost.com","The highly anticipated results of a clinical trial for the pill, daraxonrasib, have been released, giving doctors hope for treating the stubbornly lethal...",{"title":122,"url":123,"domain":124,"snippet":125,"content":45},"Chemo Selection in Metastatic Pancreatic Cancer Continues to Evolve With KRAS-Targeted Therapies on the Horizon","https:\u002F\u002Fwww.onclive.com\u002Fview\u002Fchemo-selection-in-metastatic-pancreatic-cancer-continues-to-evolve-with-kras-targeted-therapies-on-the-horizon","onclive.com","As targeted therapies such as daraxonrasib (RMC-6236) and other KRAS inhibitors are evaluated in clinical trials, frontline treatment selection for patients...",{"title":127,"url":128,"domain":129,"snippet":130,"content":45},"Daraxonrasib Nearly Doubles OS vs Chemotherapy in Metastatic PDAC","https:\u002F\u002Fwww.targetedonc.com\u002Fview\u002Fdaraxonrasib-nearly-doubles-os-versus-chemotherapy-in-metastatic-pdac","targetedonc.com","Daraxonrasib reduced the risk of death by 60% compared with investigator's choice chemotherapy in patients with previously treated metastatic pancreatic...",{"title":132,"url":133,"domain":134,"snippet":135,"content":45},"Study: New Drug Could Dramatically Increase Pancreatic Cancer Survival","https:\u002F\u002Fwww.cedars-sinai.org\u002Fnewsroom\u002Fstudy-new-drug-could-dramatically-increase-pancreatic-cancer-survival\u002F","cedars-sinai.org","Cedars-Sinai was one of the sites for a clinical trial of a new oral medication shown to vastly improve survival in patients with advanced pancreatic cancer...",{"title":137,"url":138,"domain":139,"snippet":140,"content":45},"[ASCO 2026] Daraxonrasib emerges as the star of ASCO 2026 by winning a standing ovation","https:\u002F\u002Fwww.koreabiomed.com\u002Fnews\u002FarticleView.html?idxno=31879","koreabiomed.com","CHICAGO, Ill. – Kim Yun-mi \u002F Korea Biomedical Review correspondent -- Among the studies presented during the Plenary Session at the 2026 American Society of...",{"title":142,"url":143,"domain":144,"snippet":145,"content":45},"'A Grand Slam' in Pancreatic Cancer: Novel Pill Doubles Survival","https:\u002F\u002Fwww.medpagetoday.com\u002Fmeetingcoverage\u002Fasco\u002F121511","medpagetoday.com","CHICAGO -- RASolute 302 trial results were hailed as a game-changing breakthrough in the treatment of pancreatic cancer.",{"title":147,"url":148,"domain":149,"snippet":50,"content":45},"Daraxonrasib Extends Survival in Metastatic Pancreatic Cancer Trial","https:\u002F\u002Fwww.technologynetworks.com\u002Fdrug-discovery\u002Fnews\u002Fdaraxonrasib-extends-survival-in-metastatic-pancreatic-cancer-trial-413213","technologynetworks.com",{"title":151,"url":152,"domain":153,"snippet":154,"content":45},"Pancreatic cancer breakthrough? New drug nearly doubles survival in advanced cases","https:\u002F\u002Fwww.theweek.in\u002Fnews\u002Fhealth\u002F2026\u002F06\u002F02\u002Fpancreatic-cancer-breakthrough-new-drug-nearly-doubles-survival-in-advanced-cases.html","theweek.in","Researchers have reported that a daily oral pill, called daraxonrasib, nearly doubled survival time in patients with advanced pancreatic cancer.",{"title":156,"url":157,"domain":158,"snippet":159,"content":45},"RAS Drug Nearly Doubles Survival in Mets Pancreatic Cancer","https:\u002F\u002Fwww.medscape.com\u002Fviewarticle\u002Fras-drug-nearly-doubles-survival-metastatic-pancreatic-2026a1000ihe","medscape.com","In a 500-patient phase 3 trial, daraxonrasib extends median overall survival to 13.2 vs 6.7 months for chemotherapy in second-line metastatic pancreatic...",{"title":161,"url":162,"domain":163,"snippet":164,"content":45},"Daraxonrasib Drug Doubles Pancreatic Cancer Survival Rate in Phase 3 Trial","https:\u002F\u002Fwww.the-scientist.com\u002Fdaraxonrasib-drug-doubles-pancreatic-cancer-survival-rate-in-phase-3-trial-74578","the-scientist.com","An inhibitor targeting the RAS pathway, which is commonly mutated in cancer, could change the way doctors treat pancreatic and other cancers.",{"title":166,"url":167,"domain":124,"snippet":168,"content":45},"Daraxonrasib Meets All Primary, Key Secondary Efficacy End Points in Pretreated PDAC","https:\u002F\u002Fwww.onclive.com\u002Fview\u002Fdaraxonrasib-meets-all-primary-key-secondary-efficacy-end-points-in-pretreated-pdac","In the phase 3 RASolute 302 trial, daraxonrasib nearly doubled OS vs chemotherapy in previously treated metastatic PDAC, cutting the risk of death by 60%.",{"title":170,"url":171,"domain":172,"snippet":173,"content":45},"Investigational daily pill doubles survival in metastatic pancreatic cancer, study shows","https:\u002F\u002Fnewsroom.ucla.edu\u002Freleases\u002Finvestigational-daily-pill-daraxonrasib-doubles-survival-metastatic-pancreatic-cancer-study","newsroom.ucla.edu","Targeted therapy with the drug daraxonrasib significantly improves survival and tumor response compared with chemotherapy.",{"title":175,"url":176,"domain":129,"snippet":177,"content":45},"Daraxonrasib Demand Grows Amid Expanded Access Rollout in Metastatic PDAC","https:\u002F\u002Fwww.targetedonc.com\u002Fview\u002Fdaraxonrasib-demand-grows-amid-expanded-access-rollout-in-metastatic-pdac","FDA opens expanded access to daraxonrasib for metastatic pancreatic cancer, as phase 3 data boost survival and clinics race to manage access hurdles.",{"title":179,"url":180,"domain":181,"snippet":182,"content":45},"Revolution Medicines’ daraxonrasib doubles survival in Phase III pancreatic cancer trial","https:\u002F\u002Fwww.thepharmaletter.com\u002Fpharma-news\u002Frevolution-medicines-daraxonrasib-doubles-survival-in-phase-iii-pancreatic-cancer-trial","thepharmaletter.com","1 June 2026. More on this story... Revolution Medicines' daraxonrasib data published in NEJM · Biotechnology · Revolution Medicines' daraxonrasib...",{"title":184,"url":185,"domain":186,"snippet":187,"content":45},"Daily pill doubles survival time for pancreatic cancer patients","https:\u002F\u002Fwww.bbc.com\u002Fnews\u002Farticles\u002Fcy82l435171o","bbc.com","The drug, daraxonrasib, has been hailed as a breakthrough in managing the deadliest of all the major cancers.",{"title":189,"url":190,"domain":191,"snippet":192,"content":45},"Revolution's pancreatic cancer drug doubles survival, boosts quality of life","https:\u002F\u002Fwww.reuters.com\u002Fbusiness\u002Fhealthcare-pharmaceuticals\u002Frevolutions-pancreatic-cancer-drug-doubles-survival-boosts-quality-life-2026-05-31\u002F","reuters.com","Revolution Medicine's experimental pancreatic cancer pill doubled survival compared with chemotherapy and improved symptoms enough that ​some patients could...",{"title":194,"url":195,"domain":109,"snippet":196,"content":45},"PanCAN Statement on Positive Overall Survival Results from Revolution Medicines Phase III Trial at ASCO","https:\u002F\u002Fpancan.org\u002Fpress-releases\u002Fpancan-statement-on-positive-overall-survival-results-from-revolution-medicines-phase-iii-trial-at-asco\u002F","The Pancreatic Cancer Action Network (PanCAN), the leading organization dedicated to advancing progress against pancreatic cancer, released a statement...",{"title":198,"url":199,"domain":200,"snippet":201,"content":45},"Revolution Medicines announces doubled survival in metastatic pancreatic cancer","https:\u002F\u002Fbiostock.se\u002Fen\u002F2026\u002F06\u002Frevolution-medicines-meddelar-fordubblad-overlevnad-vid-spridd-pankreascancer\u002F","biostock.se","The phase III RASolute 302 trial shows that the targeted therapy daraxonrasib doubles median survival in metastatic pancreatic cancer compared to standard...",{"title":203,"url":204,"domain":205,"snippet":206,"content":45},"Daraxonrasib Doubles Survival in Pancreatic Cancer at ASCO 2026: A Game-Changer","https:\u002F\u002Fwww.oncologynewscentral.com\u002Fpancreatic-cancer\u002Fstanding-ovation-at-asco-2026-for-grand-slam-pancreatic-cancer-data-daraxonrasib-doubles-survival","oncologynewscentral.com","Explore how daraxonrasib is transforming pancreatic cancer treatment by doubling survival rates, as showcased at ASCO 2026.",{"title":208,"url":209,"domain":210,"snippet":211,"content":45},"After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses","https:\u002F\u002Fwww.nbcnews.com\u002Fhealth\u002Fhealth-news\u002Fnew-drugs-unprecedented-results-pancreatic-cancer-doctors-look-uses-rcna346818","nbcnews.com","The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove effective for lung,...",{"title":213,"url":214,"domain":215,"snippet":216,"content":45},"ASCO 2026: Multi-selective RAS(ON) inhibitor yields unprecedented survival gains for metastatic pancreatic cancer","https:\u002F\u002Fwww.oncology-central.com\u002Fasco-2026-multi-selective-rason-inhibitor-yields-unprecedented-survival-gains-for-metastatic-pancreatic-cancer\u002F","oncology-central.com","Original story from the ASCO Annual Meeting. Results from the first phase 3 trial of a RAS(ON) multi-selective inhibitor show that daraxonrasib is effective...",{"title":218,"url":219,"domain":220,"snippet":221,"content":45},"‘Unprecedented’ Revolution data point to paradigm shift in pancreatic cancer","https:\u002F\u002Fwww.biopharmadive.com\u002Fnews\u002Frevolution-daraxonrasib-asco-2026-rasolute-study-results\u002F821555\u002F","biopharmadive.com","Highly anticipated data presented at ASCO confirmed what's been heralded as a medical breakthrough against a historically tough-to-treat tumor.",{"title":223,"url":224,"domain":225,"snippet":226,"content":45},"Revolution Medicines starts shipping experimental pancreatic cancer drug","https:\u002F\u002Fwww.statnews.com\u002F2026\u002F05\u002F30\u002Fpancreatic-cancer-daraxonrasib-revolution-medicines-early-access-asco-2026\u002F","statnews.com","After life-extending data, CEO Mark Goldsmith tells STAT demand for daraxonrasib is high and that the company will file soon for FDA approval.",{"title":228,"url":229,"domain":230,"snippet":231,"content":45},"New drug nearly doubles survival rates in some pancreatic cancer patients, study says","https:\u002F\u002Fwww.cbsnews.com\u002Fnews\u002Fpancreatic-cancer-treatment-daraxonrasib-survival-rate\u002F","cbsnews.com","New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.",{"title":233,"url":234,"domain":225,"snippet":235,"content":45},"'Stunning results' for Revolution Medicines pancreatic cancer drug | STAT","https:\u002F\u002Fwww.statnews.com\u002F2026\u002F05\u002F31\u002Fpancreatic-cancer-daraxonrasib-revolution-medicines-results-asco-2026\u002F","In one of the deadliest cancers, daraxonrasib nearly doubled survival time compared to standard chemotherapy, researchers report at ASCO.",{"title":237,"url":238,"domain":239,"snippet":240,"content":45},"Experimental pill promises new hope for deadly pancreatic cancer","https:\u002F\u002Fwww.cnbc.com\u002F2026\u002F05\u002F31\u002Fexperimental-pill-promises-new-hope-for-deadly-pancreatic-cancer.html","cnbc.com","Those taking daraxonrasib lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients.",{"title":242,"url":243,"domain":244,"snippet":245,"content":45},"Experimental pancreatic cancer drug offers new hope in major trial","https:\u002F\u002Fabc7news.com\u002Famp\u002Fpost\u002Fexperimental-pancreatic-cancer-drug-offers-new-hope-major-trial\u002F19212530\u002F","abc7news.com","An experimental drug for metastatic pancreatic cancer nearly doubled overall survival in a Phase 3 clinical trial, offering new hope for patients with one...",{"title":247,"url":248,"domain":249,"snippet":250,"content":45},"A new pill can double survival time for deadliest cancer: An expert explains why this is a gamechanger","https:\u002F\u002Findianexpress.com\u002Farticle\u002Fexplained\u002Fexplained-health\u002Fdaraxonrasib-pancreatic-cancer-survival-trial-results-10721700\u002F","indianexpress.com","Daraxonrasib nearly doubles survival time in pancreatic cancer patients, offering hope for a disease that is notoriously difficult to treat.",{"title":151,"url":252,"domain":153,"snippet":154,"content":45},"https:\u002F\u002Fwww.theweek.in\u002Fnews\u002Fhealth\u002F2026\u002F06\u002F02\u002Fpancreatic-cancer-breakthrough-new-drug-nearly-doubles-survival-in-advanced-cases.amp.html",{"title":254,"url":255,"domain":256,"snippet":257,"content":45},"Patients, doctors hail 'revolutionary' new drug for pancreatic cancer","https:\u002F\u002Fchicago.suntimes.com\u002Fhealth\u002F2026\u002F05\u002F26\u002Fpancreatic-cancer-daraxonrasib-early-access-treatment","chicago.suntimes.com","The treatment should become “a new standard of care” for previously treated metastatic pancreatic cancer, said Dr. Brian Wolpin of the Dana-Farber Cancer...",{"title":237,"url":259,"domain":260,"snippet":261,"content":45},"https:\u002F\u002Fwww.npr.org\u002F2026\u002F05\u002F31\u002Fnx-s1-5841859\u002Fexperimental-pill-new-hope-pancreatic-cancer","npr.org","A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one...",{"title":263,"url":264,"domain":265,"snippet":266,"content":45},"Pancreatic Cancer Drug Doubles Survival While Reducing Side Effects","https:\u002F\u002Fwww.insideprecisionmedicine.com\u002Ftopics\u002Foncology\u002Fpancreatic-cancer-drug-doubles-survival-while-reducing-side-effects\u002F","insideprecisionmedicine.com","Revolution Medicines reports that its investigational drug daraxonrasib doubled the overall survival of patients with metastatic pancreatic cancer compared...",{"title":268,"url":269,"domain":270,"snippet":271,"content":45},"RASolute 302 Brings a “Transformative” Moment in Pancreatic Cancer: A 60% Improvement in Overall Survival","https:\u002F\u002Fwww.ajmc.com\u002Fview\u002Frasolute-302-brings-a-transformative-moment-on-pancreatic-cancer-a-60-improvement-in-overall-survival","ajmc.com","An entirely new approach to treating one of the most intractable cancers could turn it into a chronic disease.",{"title":273,"url":274,"domain":275,"snippet":276,"content":45},"ASCO26: Revolution's 'grand slam' data in pancreatic cancer","https:\u002F\u002Fpharmaphorum.com\u002Fnews\u002Fasco26-revolutions-grand-slam-data-pancreatic-cancer","pharmaphorum.com","Revolution Medicines' pan-RAS(on) inhibitor daraxonrasib has delivered an unprecedented result in pancreatic cancer.",{"title":278,"url":279,"domain":280,"snippet":281,"content":45},"Doctors stood up and cheered this historic pancreatic-cancer treatment in the middle of an oncology-conference presentation","https:\u002F\u002Fwww.marketwatch.com\u002Fstory\u002Fwhy-doctors-stood-up-and-cheered-mid-presentation-for-a-historic-pancreatic-cancer-treatment-15406029","marketwatch.com","Revolution Medicines' experimental pancreatic cancer drug got a standing ovation at a weekend oncology meeting in Chicago. Photo: Getty Images...",{"title":283,"url":284,"domain":285,"snippet":286,"content":45},"Daraxonrasib Doubles Survival Time for Advanced Pancreatic Cancer","https:\u002F\u002Fwww.cancerhealth.com\u002Farticle\u002Fdaraxonrasib-doubles-survival-time-advanced-pancreatic-cancer","cancerhealth.com","Daraxonrasib led to a 60% reduction in the risk of death compared with chemotherapy for patients with hard-to-treat metastatic disease.",{"title":288,"url":289,"domain":290,"snippet":291,"content":45},"New cancer pill almost doubles survival time for patients during trial","https:\u002F\u002Fwww.independent.co.uk\u002Fnews\u002Fhealth\u002Fpancreatic-cancer-symptoms-pill-daraxonrasib-b2986710.html","independent.co.uk","Daraxonrasib has been hailed as 'landscape-changing' for people with the disease.",{"title":293,"url":294,"domain":295,"snippet":296,"content":45},"‘Breakthrough’ pill doubles life expectancy for pancreatic cancer patients","https:\u002F\u002Fwww.telegraph.co.uk\u002Fnews\u002F2026\u002F05\u002F31\u002Fnew-pill-doubles-life-expectancy-pancreatic-cancer-patients\u002F","telegraph.co.uk","A pill that doubles life expectancy in patients with pancreatic cancer has been hailed as the biggest breakthrough for decades.",{"title":298,"url":299,"domain":300,"snippet":301,"content":45},"RAS Inhibitor Doubles Survival in Pancreatic Cancer Trial","https:\u002F\u002Fwww.miragenews.com\u002Fras-inhibitor-doubles-survival-in-pancreatic-1683474\u002F","miragenews.com","At the ASCO annual meeting, Dana-Farber's Brian Wolpin, MD, MPH, will present positive results from the RASolute 302 trial showing a substantial.",{"title":303,"url":304,"domain":305,"snippet":306,"content":45},"Daraxonrasib boosts survival in landmark Pancreatic cancer trial","https:\u002F\u002Fdiyatvusa.com\u002Fdaraxonrasib-boosts-survival-in-landmark-pancreatic-cancer-trial\u002F","diyatvusa.com","A new experimental drug from Revolution Medicines has delivered one of the most promising results ever seen in advanced pancreatic cancer...",{"title":308,"url":309,"domain":310,"snippet":311,"content":45},"How new cancer pill is allowing pancreatic cancer patients to live twice as long","https:\u002F\u002Fwww.firstpost.com\u002Fexplainers\u002Fhow-new-cancer-pill-is-allowing-pancreatic-cancer-patients-to-live-twice-as-long-14017646.html","firstpost.com","Daraxonrasib blocks a mutated protein that fuels tumour growth in over 90 per cent of pancreatic cancer cases. The findings were published in the New...",{"title":313,"url":314,"domain":315,"snippet":316,"content":45},"New pancreatic cancer pill may revolutionize treatment for the deadly disease, experts say","https:\u002F\u002Fwww.phillyvoice.com\u002Fpancreatic-cancer-drug-treatment\u002F","phillyvoice.com","Oncologists are hailing a new pancreatic cancer drug as possibly revolutionary for treatment of the aggressive and often fatal disease.",{"title":318,"url":319,"domain":320,"snippet":321,"content":45},"Finally a shred of hope for pancreatic cancer victims as new drug gives extra months of life","https:\u002F\u002Fwww.msn.com\u002Fen-us\u002Fhealth\u002Fother\u002Ffinally-a-shred-of-hope-for-pancreatic-cancer-victims-as-new-drug-gives-extra-months-of-life\u002Far-AA24u8q8","msn.com","Doctors today hailed a breakthrough in the fight against pancreatic cancer after a new drug was shown to give patients precious extra months of life.",{"title":323,"url":324,"domain":325,"snippet":326,"content":45},"'Game changer' experimental drug doubles survival time for pancreatic cancer, trial shows","https:\u002F\u002Fwww.cbc.ca\u002Fnews\u002Fhealth\u002Fexperimental-pancreatic-cancer-drug-9.7219272","cbc.ca","An experimental drug that doubles survival time for people with pancreatic cancer is being hailed as a breakthrough for combating one of the world's...",{"title":328,"url":329,"domain":330,"snippet":331,"content":45},"Pancreatic cancer pill sparks standing ovation from doctors","https:\u002F\u002Fwww.freemalaysiatoday.com\u002Fcategory\u002Fleisure\u002F2026\u002F06\u002F06\u002Fpancreatic-cancer-pill-sparks-standing-ovation-from-doctors","freemalaysiatoday.com","New trial data suggests the experimental drug could significantly extend survival in patients with advanced stages of the disease. The new drug daraxonrasib...",{"title":333,"url":334,"domain":335,"snippet":336,"content":45},"Pill can double pancreatic cancer survival time","https:\u002F\u002Fwww.femalefirst.co.uk\u002Fbizarre\u002Fpill-can-double-pancreatic-cancer-survival-time-1445294.html","femalefirst.co.uk","A breakthrough daily pill has doubled survival times in patients with advanced pancreatic cancer, prompting experts to hail the treatment as a potential...",{"title":338,"url":339,"domain":340,"snippet":341,"content":45},"Cancer 'Holy Grail' discovered in breakthrough that doubled survival for deadly disease","https:\u002F\u002Fwww.express.co.uk\u002Flife-style\u002Fhealth\u002F2211581\u002Fcancer-pancreatic-survival-drug-daraxonrasib","express.co.uk","Scientists at the world's largest cancer conference have hailed the start of a new drug 'revolution'.",{"title":343,"url":344,"domain":345,"snippet":346,"content":45},"Scientists Hail New Pancreatic Cancer Pill Breakthrough","https:\u002F\u002Fgreekcitytimes.com\u002F2026\u002F06\u002F01\u002Fscientists-hail-new-pancreatic-cancer-pill-breakthrough\u002F","greekcitytimes.com","A new targeted pill called daraxonrasib has nearly doubled survival rates for patients with advanced pancreatic cancer, raising hopes for a major...",{"title":348,"url":349,"domain":350,"snippet":351,"content":45},"Breakthrough against 'most-feared' cancer hailed by doctors as a 'game-changer'","https:\u002F\u002Fwww.scottishdailyexpress.co.uk\u002Flifestyle\u002Fhealth\u002Fbreakthrough-against-most-feared-cancer-37230393","scottishdailyexpress.co.uk","One American doctor tells the world's largest cancer conference: 'When this data came out, I actually started crying. It's such an incredibly impactful...",{"title":353,"url":354,"domain":355,"snippet":356,"content":357},"FSU chemist points to academic research behind promising pancreatic cancer treatment","https:\u002F\u002Fnews.fsu.edu\u002Fnews\u002Fexpert-pitches\u002F2026\u002F06\u002F03\u002Ffsu-chemist-points-to-academic-research-behind-promising-pancreatic-cancer-treatment\u002F","news.fsu.edu","An FSU chemist highlighted the university research underlying daraxonrasib, a promising pancreatic cancer drug that nearly doubled survival times in recent clinical trials.","!\n\nFlorida State University chemist James Frederich believes new drug discoveries like daraxonrasib underscore the importance of university research. \n\nA promising new pancreatic cancer drug that nearly doubled survival times in a recent clinical trial is drawing attention not only for its potential impact on patients, but also for the university research that helped make it possible.\n\nIn recent clinical trials by oncology company Revolution Medicines, patients who received daraxonrasib live an average of 13.2 months. The rate nearly doubled the average of 6.7 months for patients in the study who received standard chemotherapy.\n\nPancreatic cancer has a five-year survival rate of about 3% once it spreads to other parts of the body. Daraxonrasib targets the KRAS gene, which was once deemed  Breakthroughs by university scientists helped lay the foundation for collaboration between universities and biotech companies that led to the drug’s development.\n\nFlorida State University chemist  is the Werner Herz Associate Professor and head of  in the FSU Department of Chemistry and Biochemistry. He focuses on developing new strategies and tactics to prepare architecturally complex natural products that exhibit important biological activity in living systems. Frederich’s research specialties include chemical biology, synthesis and catalysis.\n\nFrederich said the success of daraxonrasib reflects the vital role universities play in advancing high-risk scientif\n\n[Content truncated...]",{"title":359,"url":360,"domain":43,"snippet":361,"content":45},"Three-drug strategy forces pancreatic tumors into lasting regression","https:\u002F\u002Fwww.news-medical.net\u002Fnews\u002F20260602\u002FThree-drug-strategy-forces-pancreatic-tumors-into-lasting-regression.aspx","A triple-targeted preclinical therapy combining daraxonrasib, afatinib, and SD36 drove durable pancreatic cancer regression by blocking KRAS\u002FRAS, EGFR\u002FHER2,...",{"title":363,"url":364,"domain":365,"snippet":366,"content":45},"Top 5 Highlights from ASCO 2026: Moores Cancer Center at the Forefront","https:\u002F\u002Ftoday.ucsd.edu\u002Farea-story\u002Ftop-5-highlights-from-asco-2026-moores-cancer-center-at-the-forefront","today.ucsd.edu","The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago was defined by practice-changing results and urgent conversations about the...",{"title":368,"url":369,"domain":370,"snippet":371,"content":45},"Breakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an ‘undruggable’ disease","https:\u002F\u002Fwww.southernminn.com\u002Faround_the_web\u002Fcommunity\u002Fbreakthrough-drug-nearly-doubles-survival-with-advanced-pancreatic-cancer-an-oncologist-explains-how-daraxonrasib-overcame\u002Farticle_46f6f434-c444-5d41-9976-a60168b40df9.html","southernminn.com","Around 97% of patients with advanced pancreatic cancer die within five years. Researchers have figured out a way to target the mechanism that makes these...",{"title":373,"url":374,"domain":59,"snippet":375,"content":45},"Tango Therapeutics Reports Encouraging Initial Phase 1\u002F2 Data on Vopimetostat and Daraxonrasib Combination for Treatment of MTAP-Deleted Pancreatic Cancer","https:\u002F\u002Fwww.quiverquant.com\u002Fnews\u002FTango+Therapeutics+Reports+Encouraging+Initial+Phase+1%2F2+Data+on+Vopimetostat+and+Daraxonrasib+Combination+for+Treatment+of+MTAP-Deleted+Pancreatic+Cancer","Tango Therapeutics reported promising Phase 1\u002F2 trial results for vopimetostat and daraxonrasib in metastatic pancreatic cancer.",{"title":377,"url":378,"domain":379,"snippet":380,"content":45},"A drug for pancreatic cancer shows immense promise, but we shouldn’t forget research in the field is a story of small victories","https:\u002F\u002Fworld.infonasional.com\u002Fpancreatic-cancer-drug-research-progress","world.infonasional.com","A drug for pancreatic cancer shows immense promise, but we shouldn't forget research in the field is a story of small victories. It is unlikely that.",{"mentionsLast7Days":382,"mentionsLast30Days":382,"firstSeen":32,"lastSeen":383,"relatedEntities":384},5,"2026-06-06T01:27:23.430Z",[36,42,48,53,58,63,68,73,78,83],[386,389,392,395,398,401],{"topic":387,"slug":388,"score":29,"type":30,"country":26,"nicheIcon":25},"Recent advances in psychiatric research tools and treatments","recent-advances-in-psychiatric-research-tools-and-treatments",{"topic":390,"slug":391,"score":29,"type":30,"country":26,"nicheIcon":25},"E-clinical solutions market size and industry analysis","e-clinical-solutions-market-size-and-industry-analysis",{"topic":393,"slug":394,"score":29,"type":30,"country":26,"nicheIcon":25},"Pharmaceutical and biotech adoption of advanced clinical trials technologies","pharmaceutical-and-biotech-adoption-of-advanced-clinical-trials-technologies",{"topic":396,"slug":397,"score":29,"type":30,"country":26,"nicheIcon":25},"Anti-inflammatory treatment targeting immune system for depression","anti-inflammatory-treatment-targeting-immune-system-for-depression",{"topic":399,"slug":400,"score":29,"type":30,"country":26,"nicheIcon":25},"Emerging diagnostic tools for earlier Parkinson’s disease detection","emerging-diagnostic-tools-for-earlier-parkinson-s-disease-detection",{"topic":402,"slug":403,"score":29,"type":30,"country":26,"nicheIcon":25},"Reasons mice are used as models in medical research","reasons-mice-are-used-as-models-in-medical-research"]